基于次致命损伤的通用数学方法,用于改进克隆基因生存曲线在高热,放射治疗和超越时平坦化的建模
Adriana M De Mendoza1,2, Soňa Michlíková2,3, Paula S Castro4
1Physics Department, Pontificia Universidad Javeriana, Carrera 7 N 40 - 62, Bogotá, 110231, Colombia.
Physics in medicine and biology
|January 6, 2025
概括
一个新的统一数学模型 (Umodel) 准确地预测了高热 (HT) 和放射治疗 (RT) 治疗的细胞存活率,包括组合疗法和存活曲线平整. 该模型使用亚致命损伤 (SLD) 积累原理来更好地预测瘤反应.
科学领域:
- 数学生物学 数学生物学
- 辐射瘤学 辐射瘤学
- 生物物理学的生物物理.
背景情况:
- 数学模型对于理解生物系统对高热 (HT) 和放射治疗 (RT) 等治疗的反应至关重要.
- 现有的模型往往难以预测HT和RT组合的细胞存活率,或解释在某些细胞培养物中观察到的生存曲线平整.
- 需要采用统一的方法来模拟单一治疗和基于一般原则的组合的细胞失活.
研究的目的:
- 开发一种先进的数学模型,能够预测单独或组合的高热和放射治疗的细胞存活结果.
- 将次致命损伤 (SLD) 积累和剂量依赖的恢复率纳入统一模型 (Umodel).
- 为了准确地复制这些疗法所观察到的生存曲线平现象.
主要方法:
- 提出了一种新的数学方法,扩展了荣格的热诱导细胞失活模型.
- 细胞死亡和增殖停止的潜在致命损害 (SLD) 积累的内置原则.
- 综合剂量依赖的恢复率以模型改变SLD恢复.
主要成果:
- 开发的统一模型 (Umodel) 准确地描述了HT和RT的细胞存活数据,以及它们的同时组合.
- 在各种克隆细胞存活数据集中,Umodel表现出强大的性能 (R2 = 0.95).
- 该模型成功地复制了生存曲线平整现象.
结论:
- 该Umodel提供了一个单一的统一数学函数,该函数基于一般化的SLD积累原理,无论治疗方式如何,都适用.
- 该模型可以复制多种类型的克隆基因生存曲线模式,包括平坦化,反映细胞反应变异性,并可能改善瘤反应预测.
- 该方法促进了进一步的模型开发,用于预测不同顺序和恢复间隔的顺序治疗的结果.
更多相关视频
05:39Author Spotlight: Radiotherapy and Clonogenic Assays for Advancing Cancer Research and Personalized Medicine
Published on: April 5, 2024
759
06:20Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
Published on: March 11, 2021
7.2K
相关概念视频
Cancer Survival Analysis
328
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
328
Kaplan-Meier Approach
90
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
90
Comparing the Survival Analysis of Two or More Groups
146
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
146
